lysakare
advanced accelerator applications - l-arginine hydrochloride, l-lysine hydrochloride - radiation injuries - detoxifying agents for antineoplastic treatment - lysakare is indicated for reduction of renal radiation exposure during peptide-receptor radionuclide therapy (prrt) with lutetium (177lu) oxodotreotide in adults.
lysakare solution for infusion 25g 25g
novartis (singapore) pte ltd - l-arginine hydrochloride; l-lysine hydrochloride - infusion, solution - l-arginine hydrochloride 25 g/l; l-lysine hydrochloride 25 g/l
arginine 25g/1litre / lysine 25g/1litre infusion bags
special order - l-arginine monohydrochloride; l-lysine monohydrochloride - infusion - 25mg/1ml ; 25mg/1ml